Invention Grant
- Patent Title: Antimicrobial compositions comprising minocycline and degradation products of oxidized cellulose
-
Application No.: US17345728Application Date: 2021-06-11
-
Publication No.: US11690937B2Publication Date: 2023-07-04
- Inventor: Eve Montia , Dwayne Looney , Theresa Scheuble , Ronen Eavri , Roi Mashiach
- Applicant: Omrix Biopharmaceuticals Ltd. , Ethicon, Inc.
- Applicant Address: IL NJ Rehovot
- Assignee: Omrix Biopharmaceuticals Ltd.,Ethicon, Inc.
- Current Assignee: Omrix Biopharmaceuticals Ltd.,Ethicon, Inc.
- Current Assignee Address: IL Rehovot; US NJ Sommerville
- Agent David R. Crichton
- Priority: IL 6325 2017.12.14
- The original application number of the division: US16195909 2018.11.20
- Main IPC: A61L31/16
- IPC: A61L31/16 ; A61P31/04 ; A01N1/00 ; A61L27/54 ; C12N5/00 ; A61L27/20 ; A61K31/717 ; A61K31/65 ; A61L15/28 ; A61L15/44 ; A61L26/00
Abstract:
Provided is an antimicrobial composition comprised of at least one degradation product of oxidized cellulose (OC), such as oxidized regenerate cellulose (ORC), and minocycline, methods of preparation thereof and uses thereof.
Public/Granted literature
- US20210316048A1 ANTIMICROBIAL COMPOSITIONS COMPRISING MINOCYCLINE AND DEGRADATION PRODUCTS OF OXIDIZED CELLULOSE Public/Granted day:2021-10-14
Information query
